Resmed (RSMDF) Interest Expenses (2016 - 2022)

Resmed has reported Interest Expenses for 7 years, with the latest figure at $5.5 million in Q1 2022.

• For the quarter ending Q1 2022, Interest Expenses fell 6.2% year-over-year to $5.5 million; the trailing twelve-month figure through Dec 2022 stood at $5.5 million (down 76.02% YoY), and the FY2021 full-year result was $24.0 million, down 40.59% from the prior year.
• Interest Expenses for Q1 2022 stood at $5.5 million, down from $5.9 million in the prior quarter.
• The five-year high for Interest Expenses was $12.5 million in Q2 2019, with the low at $3.7 million in Q3 2018.
• Historically, Interest Expenses has averaged $7.7 million across 5 years, with a median of $6.7 million in 2020.
• Annual changes were most pronounced in 2018 — Interest Expenses slumped 52.37% — and 2019, when it jumped 196.44%.
• Resmed's Interest Expenses stood at $7.5 million in 2018, then soared by 36.5% to $10.2 million in 2019, then sank by 43.33% to $5.8 million in 2020, then rose by 2.69% to $5.9 million in 2021, then decreased by 8.17% to $5.5 million in 2022.
• The last three Interest Expenses figures came in at $5.5 million (Q1 2022), $5.9 million (Q4 2021), and $5.4 million (Q3 2021), per Business Quant data.